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Abstract
Background Type D personality is a risk indicator in
cardiac patients. The validity and reliability of the Type D
Scale (DS14) have been confirmed in Western Europe but
not outside this context.
Purpose We examined the structural, convergent, and
divergent validity and the reliability of the DS14 in the
Ukrainian setting.
Method Healthy Ukrainian respondents (n=250) completed
the DS14, the Eysenck Personality Questionnaire, the State
Trait Anxiety Inventory, and the Beck Depression Invento-
ry. A subsample (n=57) completed the DS14 again after
4 weeks.
Results The prevalence of Type D personality was 22.4%.
The two-factor structure and the validity of the DS14 were
confirmed. The DS14 subscales were internally consistent
(Cronbach’s α=0.86/0.71; mean inter-item correlation=
0.48/0.27) and stable over a 4-week period (r=0.85/0.63).
Type D individuals had significantly higher mean scores on
anxiety (p<0.001), depressive symptoms (p<0.001), and
negative affect (p<0.001), and lower scores on positive
affect (p<0.001) compared to non-Type D individuals.
Conclusion Preliminary evidence suggests that the Ukrai-
nian DS14 is a valid and reliable measure. Future studies
are warranted to test the utility of the scale in cardiac
patients in the Ukraine, including whether Type D also
predicts adverse health outcomes beyond the boundaries of
Western Europe.
Keywords Anxiety.Cross-culturalvalidity.Depression.
Positiveaffect.TypeDpersonality
Introduction
The distressed (Type D) personality is a risk indicator for
multiple health outcomes in patients with cardiovascular
disease (CVD), including mortality, morbidity, impaired
health status, emotional distress, and exhaustion [1, 2].
The impact of Type D on CVD prognosis is independent
of biomedical risk factors, including disease severity as
measured by left ventricular ejection fraction, indicating
that the cardio-toxicity of Type D cannot be attributed to
these patients being more severely ill [3–5]. Similarly,
Type D personality exerts its deleterious effects on health
outcomes independent of treatment [6–9] and mood states,
such as anxiety and depression [3, 5, 6].
The Type D personality construct was originally devel-
oped in Belgian patients with ischemic heart disease, but
the value of the construct has subsequently been confirmed
in patients with peripheral arterial disease [10], chronic
heart failure [11], arrhythmia [12], and in patients treated
with revascularization procedures [5, 7, 10, 12–14]. Type D
personality is defined by the co-occurrence of a high score
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e-mail: s.s.pedersen@uvt.nlon the two normal and stable personality traits, negative
affectivity and social inhibition [15]. Type D patients tend
to experience increased negative emotions while not
expressing these emotions, with these patients typically
having a gloomy view of life, feeling sad, being closed, and
feeling inhibited in social interactions [15].
Type D personality can be assessed with the brief, valid,
and reliable Type D Scale (DS14) [15]. Despite current
preliminary evidence on Type D as a risk indicator in CVD,
with Type D fulfilling several external criteria set out for
evaluating new risk indicators and risk markers [1] and the
validity and reliability of the scale being established in
Belgian [15], German [16], Italian [17], and Danish [18]
populations, its generalizability has not yet been investi-
gated outside the Western European context. Hence, in the
current study, we examined the structural, convergent, and
divergent validity, and the reliability of the Type D Scale in
the Ukrainian setting.
Methods
Participants
Of 281 students approached for participation from Volyn
State University, Lutsk, Ukraine, 250 (89%; 45.2% men;
mean age (years)=20.9±3.4) agreed to participate and
completed a set of psychological questionnaires. The 250
students came from four disciplines, that is Physical
Rehabilitation (57.6%), Computer Engineering (14.0%),
Marketing (15.2%), and Law (13.2%). A subsample of 57
students completed the DS14 again at 4 weeks in order to
examine the test–retest stability of the scale. The protocol
was approved by the ethics committee of Lutsk City
Hospital. All participants provided written informed con-
sent, and the study was carried out in accordance with the
Helsinki Declaration.
Materials
Type D Personality
We used the DS14 to evaluate Type D personality, which
was translated into the Ukrainian language according to
standard procedures [15]. The 14 items are divided into two
seven-item subscales, that is, negative affectivity (e.g. “I
often feel unhappy”) and social inhibition (e.g. “Ia ma
closed person”)[ 15]. Responses to items are indicated on a
five-point Likert scale from 0 (false) to 4 (true) (score range
0–28 for each subscale). Type D caseness is derived on the
basis of a standardized cut-off ≥10 on both subscales [15],
with item response theory showing that all items have the
highest measurement precision around this cut-off [19]. The
DS14 has good psychometric properties, with Cronbach’s
α=0.88/0.86 and 3-month test–retest reliability r=0.72/
0.82 for the negative affectivity and social inhibition
subscales, respectively [15].
Neuroticism and Extroversion
Neuroticism (24 items) and extroversion (24 items) were
assessed with the Eysenck Personality Questionnaire (EPQ;
[20]). These subscales were included in order to examine
the construct validity of the DS14, as they comprise
theoretically similar constructs to the negative affectivity
and social inhibition subscales of the DS14. All items are
answered with 0 (no) or 1 (yes), with a high score
indicating more of the personality trait. The validity and
reliability of the two subscales have proven satisfactory in
the Ukrainian setting [20].
Anxiety
The State-Trait Anxiety Inventory (STAI) is a 40-item
measure that assesses state and dispositional anxiety [21,
22]. Items contribute with 20 items to each state and trait
subscale and are answered on a four-point Likert scale from
1 (not at all) to 4 (very much so) (score range, 20–80), with
a higher score indicating more anxiety. For the current
study, we only used the state version of the STAI to
examine the construct validity of the DS14. The STAI is a
valid and reliable measure, with Cronbach’s α ranging from
0.89 to 0.94 [21].
Depression
The 21-item Beck Depression Inventory (BDI), assessing
cognitive, affective, and somatic symptoms of depression,
was included in the current study to examine the construct
validity of the DS14 [23, 24]. The BDI is a frequently used
measure of depressive symptoms in CVD patients and has
been shown to predict mortality [25]. Items are answered
on a three-point scale from 0 to 3 (score range, 0–63), with
a higher score indicating more severe depressive symptom-
atology. The psychometric properties of the BDI are good,
with Cronbach’s α ranging from 0.76 to 0.95 in psychiatric
populations and 0.73 to 0.92 in non-psychiatric populations
[25].
Negative and Positive Affect
The Global Mood Scale (GMS) is a 20-item measure of
negative and positive affect, with ten items contributing to
each subscale [26]. Items are rated on a five-point Likert
scale ranging from 0 (not at all) to 4 (extremely), with a
score range from 0 to 40 for both subscales. The GMS is an
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from 0.87 to 0.94 for the negative affect subscale and 0.85–
0.91 for the positive affect subscale [26–28]. The GMS has
been shown to be responsive to tap treatment-related
changes following cardiac rehabilitation in CVD patients
[27]. The GMS was included to evaluate the construct
validity of the DS14.
Statistical Analyses
Prior to statistical analyses, missing items were replaced
with the mean of the completed items belonging to that
subscale. The number of missing on the items of the
psychological questionnaires was less than 2% on any
given item. Nominal variables were compared with the chi-
square test and continuous variables with Student’s t test for
independent samples. Exploratory factor analysis (EFA)
with varimax rotation was used to examine the structural
validity of the DS14. A higher order factor analysis of scale
scores (i.e., the DS14, EPQ, STAI, BDI, and GMS) and
Pearson’s correlations were used to examine the convergent
and divergent construct validity of the DS14. For both
factor analyses, the scree plot was used to determine the
number of factors to extract. Confirmatory factor analysis
(CFA) was used to test the factor structure found with EFA.
The χ
2, Tucker–Lewis Index (TLI >0.90 acceptable; [29]),
the Comparative Fit Index (CFI: >0.90 acceptable; [30])
and the root mean square error of approximation (RMSEA
<0.08 acceptable; [31]) were used as goodness-of-fit
indices. The internal consistency of the DS14 subscales
was assessed with Cronbach’s α a n dw i t ht h em e a ni n t e r -
item correlation (MIIC). MIIC was used in addition to
Cronbach’s α, since Cronbach’s α is highly dependent on
the number of items in a scale and hence prone to be
inflated when the number of items is high. MIIC should
fall in an optimal range between 0.20 to 0.50 [32]b u t
should be no less than 0.15 [33]. The temporal stability of
the DS14 subscales was examined with Pearson’sc o r r e -
lations and paired t tests. Mean scores on anxiety,
depression, negative affect (GMS), and positive affect
(GMS) stratified by Type D personality were analyzed
with multivariate analysis of variance (MANOVA) to
adjust for multiple comparisons. All tests were two-tailed.
AMOS 7.0 was used to conduct the CFA. All other
analyses were performed using SPSS 14.0 for Windows.
Results
Prevalence of Type D Personality
The prevalence of Type D personality in the Ukrainian
sample was 22.4% (56/250). The prevalence of Type D was
higher in women compared to men [27.7% (38/137) vs
15.9% (18/113); p=0.038], but Type D and non-Type D
individuals did not differ on mean age (years) (20.82±3.47
vs 20.93±3.32; p=0.84).
Structural Validity of the Ukrainian DS14
The Kaiser–Meyer–Olkin measure of sampling adequacy
(0.857) and the Bartlett’s test of sphericity (<0.001) showed
that the data fulfilled the assumptions for carrying out a
factor analysis. The results confirmed the two-factor
structure of the DS14, as indicated by the scree plot
(Fig. 1) and the factor loadings (Table 1, left), although the
factor loadings for items 3 and 11 were significantly smaller
than for any of the other items. This two-factor model
accounted for 48.8% (factor I, 36.0%; factor II, 12.7%) of
the variance.
The two-factor solution derived from the EFA was
validated using the same sample on which the EFA was
done. Figure 2 shows the final solution of the CFA. The
initial solution without correlated errors resulted in a
poor fit both from a statistical (χ
2=198;df=76,p<0.001)
and descriptive point of view (TLI=0.88; CFI=0.89;
RMSEA=0.08). However, examination of the standard-
ized residual covariances revealed that 92.4% (97 out of
105) of the observed (co)variances were well explained
by the initial model. A relatively large standardized
residual covariance (3.27) was found between items 2
and 12, which both reflect worry. This suggests that the
response to item 12 is somewhat influenced by the
response to item 2. Therefore, we assumed correlation
between the error terms of these items, resulting in an
improved and adequate descriptive fit (TLI=0.91; CFI=
0.93; RMSEA=0.07) of the model. However, the statis-
tical fit of this model remained poor (χ
2=159;df=75,p<
0.001). The estimated unstandardized regression weights
Fig. 1 Scree plot showing the eigenvalues for the DS14 factors
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Convergent and Divergent Validity
DS14 negative affectivity was positively correlated with
related constructs, such as neuroticism, anxiety, depres-
sion, and negative affect, with the shared variance
ranging from 24% (anxiety) to 50% (neuroticism;
Table 3, left). Although the overlap in variance between
DS14 negative affectivity and neuroticism was 50%, this
indicates that there are some overlaps but that the
constructs are not identical. By contrast, DS14 negative
affectivity was negatively correlated with constructs that
are conceptually different, such as extroversion and
positive affect, with shared variances of 7% and 10%.
There was an inverse relationship between DS14 social
inhibition, extroversion, and positive affect, respectively,
with shared variances of 30% and 19% (Table 3,l e f t ) .B y
contrast, the shared variance between DS14 social inhibi-
tion and negative affect measures ranged from 9% to 20%.
Taken together, these results confirm the convergent and
divergent validity of the DS14 negative affectivity and
social inhibition subscales.
A higher factor analysis on scale scores further corrob-
orated the construct validity of the DS14, with negative
affectivity, neuroticism, anxiety, depressive symptoms, and
negative affect loading on one factor, and social inhibition,
extroversion, and positive affect loading on another factor
(Table 3, right).
Internal Consistency
The internal consistency of the DS14 negative affectivity
and social inhibition subscales, as measured by Cronbach’s
α, were 0.86 and 0.71, respectively (Table 1, right). MICC
for the negative affectivity and social inhibition subscales
were 0.48 and 0.27, respectively. Both measures of internal
consistency conform to proposed guidelines, indicating a
good internal consistency [32, 33].
Temporal Stability of the Type D construct
The 4-week test–retest reliability, as measured by Pearson’s
correlation in a subsample (n=57), was r=0.85 for the
negative affectivity and r=0.63 for the social inhibition
subscales, respectively. A paired samples t test using
negative affectivity and social inhibition at baseline and
Table 1 Structural validity and internal consistency of the Ukrainian DS14
DS14 items Factor I
a Factor II
a Corrected item-total correlations
Negative affectivity
2 I often make a fuss about unimportant things 0.71 −0.02 0.57
4 I often feel unhappy 0.76 0.08 0.55
5 I am often irritated 0.77 0.09 0.66
7 I take a gloomy view of things 0.53 0.24 0.46
9 I am often in a bad mood 0.76 0.30 0.73
12 I often found myself worrying about something 0.74 0.17 0.66
13 I am often down in the dumps 0.77 0.23 0.72
Eigenvalue=5.05
Internal consistency (Cronbach’s α)=0.86 MICC=.48
Social inhibition
1 I make contact easily when I meet people
b 0.04 −0.71 0.45
3 I often talk to strangers 0.19 −0.46 0.20
6 I often feel inhibited in social interactions
b 0.40 0.62 0.53
8 I find it hard to start a conversation 0.28 0.69 0.57
10 I am a closed kind of person 0.25 0.62 0.49
11 I would rather keep other people at a distance 0.25 0.38 0.31
14 When socializing, I don’t find the right things to talk about 0.23 0.60 0.47
Eigenvalue=1.78
Internal consistency (Cronbach’s α)=0.71 MICC=0.27
MICC mean inter-item correlation
aItems assigned to a factor are presented in bold
bItems need to be reversed prior to calculating the subscale score
Int. J. Behav. Med. (2009) 16:108–115 111 111retest showed no significant differences in scale scores over
a 4-week period (negative affectivity, t=0.064, df=56; p=
0.95; social inhibition, t=0.70, df=56, p=0.49). These
results confirm the temporal stability of the DS14 during
the course of 4 weeks.
Symptomatology and Affect Stratified by Type D
Personality
Type D individuals had significantly higher mean scores on
anxiety compared to non-Type D individuals (49.13±8.39
vs 41.35±7.33, p<0.001). Similarly, mean scores on
depressive symptoms and negative affect were higher in
Type D vs non-Type D individuals, whereas positive affect
was lower in Type D individuals (Fig. 3). This further
testifies to the construct validity of Type D personality in
the Ukraine.
Discussion
This is the first study to show that the Type D personality
construct is generalizable beyond the Western European
setting, with the results providing preliminary evidence for
the cross-cultural utility of the Type D personality construct
in the Ukraine. The two-factor structure of the DS14 was
confirmed in the Ukrainian setting, and the DS14 was
shown to be a valid, reliable, and stable measure over a 4-
week period.
The results of the current study are consistent with those
of previous validation studies of the Type D construct in
Western European countries, including Belgium [15],
Germany [16], Italy [17], and Denmark [18], showing that
the Type D construct is valid and reliable. Nevertheless, the
results indicate that the internal consistency of the social
inhibition subscale of the Ukrainian version of the DS14
might be improved by replacing some of its items. These
items may be culturally sensitive items and hence difficult
to translate. An alternative explanation may be that these
items have different connotations in different cultures, with
some items not being culturally relevant outside the
Western context. However, prior to making the decision
whether to replace items of the DS14 Ukrainian version
with alternative items, it would be important to have more
data on this language version in its present form including
in patients with somatic disease, such as CVD, in which the
DS14 was originally developed.
In the current sample, the prevalence of Type D
personality was 22.4%, which compares to prevalence rates
found in other studies in the general population and healthy
samples, although there is some variation across samples [10,
15, 16, 18]. In patients with CVD, prevalence rates range
from 23% to 36%, depending on whether the diagnosis is
ischemic heart disease [9, 15, 34], chronic heart failure [11],
or peripheral arterial disease [10].
Table 2 Estimated unstandardized regression weights and covarian-
ces for the confirmatory factor analysis model with correlated errors
Item Factor Estimate SE p value
1 SI 1.00 ––
2 NA 1.00 ––
3 SI 0.51 0.21 0.013
4 NA 1.09 0.14 <0.001
5 NA 1.27 0.16 <0.001
6S I −1.73 0.26 <0.001
7 NA 0.87 0.13 <0.001
8S I −1.74 0.27 <0.001
9 NA 1.38 0.16 <0.001
10 SI −1.27 0.21 <0.001
11 SI −0.91 0.21 <0.001
12 NA 1.19 0.13 <0.001
13 NA 1.35 0.16 <0.001
14 SI −1.34 0.22 <0.001
Cov (NA, SI) −0.27 0.06 <0.001
Cov (e2, e12) 0.61 0.11 <0.001
NA
item 2
item 4
item 5
item 7
item 9
item 12
item 13
item 1
item 3
item 6
item 8
item 10
item 11
item 14
e2
e4
e5
1.27
e7
.87
e9
1.38
e12
e13
SI
e1
e3
e6 -1.73
e8
-1.74
e10
e11
e14
-.27
.61
-1.34
1.00
.51
-1.27
-.91
1.00
1.09
1.19
1.35
Fig. 2 Final confirmatory factor analysis model for the DS14. NA
negative affectivity, SI social inhibition
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of debate, with some questioning its novelty both in the
context of existing personality theory and negative affect
[35, 36]. In the current study, the DS14 negative affectivity
and social inhibition subscales were shown to be related to
but nevertheless different from the personality traits
neuroticism and extroversion. These findings are consistent
with those of previous studies examining the validity of the
DS14 [15, 16]. Similarly, in the current study, the DS14
subscales correlated with measures of negative affect, but
the shared variance did not extend beyond 32%. Recent
studies of patients treated with percutaneous coronary
intervention in the drug-eluting stent area have also shown
that Type D personality is different from negative affect,
such as anxiety [37] and vital exhaustion [13]. In addition, a
recent study lend further credence to the notion that it is
Type D personality (i.e., the co-occurrence of negative
affectivity and social inhibition) rather than the separate
influence of the traits that incurs an increased risk on
adverse prognosis [5]. In the latter study, social inhibition
was shown to moderate the effect of negative affectivity on
prognosis, with this influence being independent of mood
states, such as anxiety and depressive symptoms, and
traditional risk factors. Moreover, a recent seminal study
has shown that Type D personality but not depressive
symptoms, as measured by the Beck Depression Inventory,
was associated with the cortisol awakening response [34].
Finally, others have recently shown that Type D personality
has added value compared to traits, with both types
(including Type D personality) and traits being indepen-
dently associated with health outcomes in a large sample of
older primary care patients [38].
This study has some limitations. First, the validity and
reliability of the Ukrainian version of the DS14 was
examined in a student population, and results may not be
generalizable to patients with somatic disease, including
CVD. Second, the test–retest reliability of the Ukrainian
version of the DS14 was established only during the course
of a 4-week period, which is relatively short. Nevertheless,
this is the first study to show that the DS14 also has value
beyond the Western European setting, using valid and
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Table 3 Correlation matrix and higher order factor analysis on scale scores (DS14, EPQ, STAI, BDI, and GMS)
Correlation matrix Higher-order
Factor analysis
a
12345678 II I
1 DS14: Negative affectivity – 0.83 0.21
2 DS14: Social inhibition 0.45* – 0.29 0.76
3 EPQ: Neuroticism 0.71* 0.32* – 0.84 0.09
4 EPQ: Extroversion −0.26* −0.55* −0.16* – −0.05 −0.87
5 STAI: Anxiety 0.49* 0.36* 0.51* −0.33* – 0.63 0.38
6 BDI: Depression 0.57* 0.40* 0.54* −0.27* 0.49* – 0.73 0.28
7 GMS: Negative affect 0.55* 0.30* 0.49* −0.21* 0.47* 0.52* – 0.76 0.13
8 GMS: Positive affect −0.31* −0.44* −0.31* 0.46* −0.43* −0.38* −0.28* – −0.26 −0.72
DS14 Type-D Scale, EPQ Eysenck Personality Questionnaire, STAI State-Trait Anxiety Inventory, BDI Beck Depression Inventory, GMS Global
Mood Scale
aItems assigned to a factor are presented in bold
*p<0.01
Int. J. Behav. Med. (2009) 16:108–115 113 113reliable measures with which to examine the construct
validity and reliability of the scale.
In conclusion, the validity and reliability of the DS14
was confirmed in a Ukrainian sample of students. These
preliminary findings show that the Type D personality
construct is not merely a Western European concept, but
that the construct may also be generalized to Eastern
Europe. Future studies are warranted to test the utility of the
scale in CVD patients and patients with other somatic
diseases in the Ukraine, including whether Type D also
predicts adverse health outcomes in these patients.
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